Genmab A (GMAB) Revenue (2018 - 2026)
Genmab A (GMAB) reported Revenue of $896.0 million for Q1 2026, up 25.31% on a YoY basis from $715.0 million in Q1 2025, and down 12.33% quarter-over-quarter from $1.0 billion in Q3 2025.
Genmab A (GMAB) Revenue (2018 - 2026) Analysis & Trends
Genmab A has reported Revenue for 6 years, with the latest figure at $896.0 million in Q1 2026.
- For the quarter ending Q1 2026, Revenue rose 25.31% year-over-year to $896.0 million; the trailing twelve-month figure through Mar 2026 stood at $3.6 billion (up 22.14% YoY), and the FY2025 full-year result was $3.7 billion, up 19.19% from the prior year.
- Revenue for Q1 2026 stood at $896.0 million, down from $1.0 billion in the prior quarter.
- The five-year high for Revenue was $1.0 billion in Q3 2025, with the low at $603.0 million in Q1 2024.
- Historically, Revenue has averaged $822.3 million across 3 years, with a median of $816.0 million in 2024.
- Annual changes were most pronounced in 2025 — Revenue rose 18.57% — and 2026, when it climbed 25.31%.
- Genmab A's Revenue stood at $816.0 million in 2024, then grew by 25.25% to $1.0 billion in 2025, then slipped by 12.33% to $896.0 million in 2026.
- The last three Revenue figures came in at $896.0 million (Q1 2026), $1.0 billion (Q3 2025), and $925.0 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 5.21 Mn |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 306.30 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 2.99 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | Genmab A | 48.34 Bn | 46.82 Bn | 831.00 Mn | 896.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 896.00 Mn |
| Sep 30, 2025 | 1.02 Bn |
| Jun 30, 2025 | 925.00 Mn |
| Mar 31, 2025 | 715.00 Mn |
| Sep 30, 2024 | 816.00 Mn |
| Jun 30, 2024 | 779.00 Mn |
| Mar 31, 2024 | 603.00 Mn |
| Sep 30, 2020 | 1.72 Bn |
| Dec 31, 2019 | 1,040.00 |
| Sep 30, 2019 | 1,039.84 |
| Dec 31, 2018 | 598.60 Mn |